Pepdox
Studies
Peptides
Calculator
Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons. | Pepdox
Home
/
Search
/
PMID 37450311
Should tirzepatide be considered for early management in type 2 diabetes? Pros and cons.
Expert opinion on pharmacotherapy
2023
PMID: 37450311
View on PubMed
DOI: 10.1080/14656566.2023.2237414
Tirzepatide
Authors
Koufakis, Theocharis; Popovic, Djordje S; Papanas, Nikolaos
Keywords
Tirzepatide
incretins
legacy effect
pharmacotherapy
type 2 diabetes